Evolutionary combinatorial chemistry, a novel tool for SAR studies on peptide transport across the blood-brain barrier. Part 2. Design, synthesis and evaluation of a first generation of peptides

Journal of Peptide Science

Volumn 11, Issue 12, 2005, Pages 789-804

  Teixidó, Meritxell ^a   Belda, Ignasi ^a   Zurita, Esther ^a   Llorà, Xavier ^b   Fabre, Myriam ^c   Villaró, Senén ^c   Albericio, Fernando ^a,c   Giralt, Ernest ^a,c  

^a INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Blood brain barrier; Genetics algorithm; N methyl amino acids; Peptide transport

Indexed keywords

ARTICLE; ARTIFICIAL INTELLIGENCE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM DISEASE; COMBINATORIAL CHEMISTRY; FRAGMENTATION REACTION; GENETIC ALGORITHM; HIGH THROUGHPUT SCREENING; HUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 29444447808     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/psc.679     Document Type: Article

References (59)

1. Marx J. NGF and Alzheimer's: hopes and fears. Science 1990; 247: 408-410.
2. Scheld WM. Drug delivery to the central nervous system: General principles and relevance to therapy for infections of the central nervous system. Rev. Infect. Dis. 1989; 11: S1669-S1690.
3. Ehrlich P. Das Sauerstoffbedürfnis des Organismus; Eine Farbenanalystische Studie. 1885; Berlin, Hirschwald.
4. Goldmann EE. Die aussere und innere Sekretion des gesunden und kranken Organismus im Lichte der vitalen Farbung. Beitr. Klin. Chir. 1909; 64: 192-265.
5. Reese TS, Karnovsky MJ. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J. Cell Biol. 1967; 34: 207-217.
6. Brightmann MW, Reese TS, Feder N. Assessment with the electron-microscope of the permeability to peroxidase of cerebral endothelium and epithelium in mice and sharks. In Capillary Permeability, Crone C, Lassen NA (eds). Munksgaard: Copenhagen, 1970; 463.
7. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 1997; 23: 3-25.
8. Norinder U, Haeberlein M. Computational approaches to the prediction of blood-brain barrier distribution. Adv. Drug Deliv. Rev. 2002; 54: 291-313.
9. Van de Waterbeemd H, Camenisch G, Folkers G, Chretien JR, Raevsky OA. Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors. J. Drug Targeting 1998; 6: 151-165.
10. Kelder J, Grootenhuis PD, Bayada DM, Delbressine LP, Ploemen JP. Polar molecular surface area as a dominating determinant for oral absorption and brain permeation of drugs. Pharm. Res. 1999; 16: 1514-1519.
11. Doan KMM, Humpreys JE, Webster LO, Wring SA, Shampire LJ, Serabjit-Singh CJ, Adkinson KK, Polli JW. Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs. J. Pharmacol. Exp. Ther. 2002; 303: 1029-1037.
12. 3H-α-MSh in rat brain. Brain Res. Bull. 1976; 1: 19-26.
13. Kastin AJ, Olson RD, Schally AV, Coy DH. CNS effects of peripherally administered brain peptides. Life Sci. 1979; 25: 401-414.
14. Gray RA, Van der Velde DG, Burke CJ, Manning MC, Middaugh CR, Borchardt RT. Delta-sleep-inducing peptide: Solution conformational studies of a membrane-permeable peptide. Biochemistry 1994; 33: 1323-1331.
15. Burton PS, Conradi RA, Ho NFH, Hilgers AR, Borchardt RT. How structural features influence the biomembrane permeability of peptides. J. Pharm. Sci. 1996; 85: 1336-1340.
16. Holland JH. Adaptation in Natural and Artificial Systems. The University of Michigan Press: Ann Arbor, 1975.
17. Cecchelli R, Dehouck B, Descamps L, Fénart L, Buée-Scherrer V, Lundquist S, Rentfel M, Torpier T, Dehouck MP. In vitro model for evaluating drug transport across the blood-brain barrier. Adv. Drug Deliv. Rev. 1999; 36: 165-178.
18. Levin LA. Relationship of octanol-water partition coeficient and molecular weight to rat brain capillary permeability. J. Med. Chem. 1980; 23: 682-684.
19. Bernards MD, Hill HF. Physical and chemical properties of drug molecules governing their diffusion through the spinal meninges. Anesthesiology 1992; 77: 750-756.
20. Macheras PE, Symillides MY. Towards a quantitative approach for the prediction of the fraction of dose absorbed using the absorption potential concept. Biopharm. Drug. Dispos. 1989; 10: 43-53.
21. Nook T, Doelker E, Buri P. Intestinal absorption kinetics of various model drugs in relation to partition coefficients. Int. J. Pharm. 1988; 43: 119-129.
22. Komiya I, Park JY, Kamani A, Ho NFH, Higuchi WI. Quantitative mechanistic studies in simultaneous fluid flow and intestinal absorption using steroids as model solutes. Int. J. Pharm. 1980; 4: 249-262.
23. Ho NFH, Park JY, Morozowich W, Higuchi WI. In Design of Biopharmaceutical Properties through Prodrugs and Analogs, Roche EB (ed.). American Pharmaceutical Association, Academy of Pharmaceutical Science. Washington, DC. 1977; 136-227.
24. Van Bree JBMM, De Boer AG, Danhof M, Ginsel LA, Breimer DD. Characterisation of an in vitro blood-brain barrier: effects of molecular size and lipophilicity on cerebrovascular endothelial transport rates of drugs. J. Pharmacol. Exp. Ther. 1988; 247: 1233-1239.
25. Tavakoli-Saberi MR, Audus KL. Physicochemical factors affecting β-adrenergic antagonist permeation across cultured hamster pouch buccal epithelium. Int. J. Pharm. 1989; 56: 135-142.
26. Pardridge WM. Peptide Drug Delivery to the Brain. Raven Press: New York, 1991; 1-357.
27. Kaiser ET, Kadzy FJ. Peptides with affinity for membranes. Ann. Rev. Biophys. Chem. 1987; 16: 561-581.
28. Teixidó M, Belda I, Roselló X, González S, Fabre M, Llorà X, Bacardit J, Garrell JM, Vilaró S, Albericio F, Giralt E. Development of a genetic algorithm to design and identify peptides that can cross the blood-brain barrier. 1. Design and validation in silico. QSAR Comb. Sci. 2003; 22: 745-753.
29. Teixidó M, Albericio F, Giralt E. Solid-phase synthesis and characterization of N-methyl rich peptides. J. Pept. Res. 2005; 65: 153-166.
30. Falb E, Yechezkel T, Salitra Y, Gilon C. In situ generation of Fmoc-amino acid chlorides using bis-(trichloromethyl)carbonate and its utilization for difficult couplings in solid-phase peptide synthesis. J. Pept. Res. 1999; 53: 507-517.
31. Merrifield RB, Mitchell AR, Clarke JE. Detection and prevention of urethane acylation during solid-phase peptide synthesis by anhydride methods. J. Org. Chem. 1974; 39: 660-668.
32. Merrifield RB, Singer J, Chait BT. Mass spectrometric evaluation of synthetic peptides for deletions and insertions. Anal. Biochem. 1988; 174: 399-414.
33. Urban J, Vaisar T, Shen R, Lee MS. Lability of N-alkylated peptides towards TFA cleavage. Int. J. Pept. Prot. Res. 1996; 47: 182-189.
34. Juhler M. Simultaneous determination of regional cerebral blood flow, glucose metabolism, and pH in acute experimental allergic encephalomyelitis. J. Cerebr. Blood Flow Metab. 1987; 7: 578-584.
35. De Boer AG, De Vries HE, De Lange ECM, Danhof M, Kuiper J, Breimer DD. Drug transport to the brain: in vitro versus in vivo approaches. J. Contr. Ret. 1994; 28: 259-263.
36. Benveniste H, Huttermeier PC. Microdialysis: Theory and applications. Progress Neurobiol. 1990; 35: 195-215.
37. Meyer HH. Zur Theorie der Alkoholnarkose. Arch. Exp. Pathol. Pharmakol. 1899; 42: 109-118.
38. Overton E. Studien Uber Die Narkose. Fischer Verlag: Jena, Germany, 1901.
39. Rogers JA, Wong A. The temperature dependence and thermodynamics of partitioning of phenols in the n-octanol-water system Int. J. Pharm. 1980; 6: 339-348.
40. Tao P, Wang R, Lai L. Calculating partition coefficients of peptides by the addition method. J. Mol. Model. 1999; 5: 189-195.
41. Katz Y, Diamond J M. A method for measuring nonelectrolyte partition coefficient between liposomes and water. J. Membr. Biol. 1974; 17: 69-86.
42. Betageri GV, Rogers JA. Thermodynamics of partitioning of β-blockers in the n-octanol-buffer and liposome systems. Int. J. Pharm. 1987; 36: 165-173.
43. Reig F, Busquets MA, Haro I, Rabanal F, Alsina MA. Interaction of opiate molecules with lipid monolayers and liposomes. J. Pharm. Sci. 1992; 81: 546-550.
44. Pidgeon C, Venkataran UV. Immobilized artificial membrane chromatography: supports composed of membrane lipids. Anal. Biochem. 1989; 176: 36-47.
45. Pidgeon C, Stevens J, Otto S, Jefcoate C, Marcus C. Immobilized artificial membrane chromatography: rapid purification of functional membrane proteins. Anal. Biochem. 1991; 194: 163-173.
46. Chui WK, Wainer I. Enzyme-based high-performance liquid chromatography supports as probes of enzyme activity and inhibition: the immobilization of trypsin and α-chymotrypsin on an immobilized artificial membrane high-performance liquid chromatography support. Anal. Biochem. 1992; 201: 237-245.
47. Braddy AC, Janaky T, Prokai L. Immobilized artificial membrane chromatography coupled with atmospheric pressure ionization mass spectrometry. J. Chrom. A 2002; 966: 81-87.
48. Pidgeon C, Ong S, Liu H, Qiu X, Pidgeon M, Dantzig AH, Munroe J, Hornback WJ, Kasher JS. IAM chromatography: an in vitro screen for predicting drug membrane permeability. J. Med. Chem. 1995; 38: 590-594.
49. Artursson P, Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 1991; 175: 880-885.
50. Otis KW, Avery ML, Broward-Partin SM, Hansen DK, Behlow HW, Scott DO, Thompson TN. Evaluation of the BBMEC model for screening the CNS permeability of drugs. J. Pharmacol. Toxicol. Meth. 2001; 45: 71-77.
51. Dehouck MP, Dehouck B, Schluep C, Lemaire M, Cecchelli R. Drug transport to the brain: comparison between in vitro and in vivo models of the blood-brain barrier. Eur. J. Pharm. Sci. 1995; 3: 357-365.
52. Banks WA, Schally AV, Barrrera CM, Fasold MB, Durham DA, Csernus VJ, Groot K, Kastin AJ. Permeability of the murine blood-brain barrier to some octapeptide analogs of somatostatin. Proc. Natl Acad. Sci. USA 1990; 87: 6762-6766.
53. Van Bree JBMM, De Boer AG, Verhoef JC, Danhof M, Breimer DD. Transport of vasopressin fragments across the blood-brain barrier: in vitro studies using monolayer cultures of bovine brain endothelial cells. J. Pharm. Exp. Ther. 1989; 249: 901-905.
54. 5]enkephalin opioid analogs. J. Pharm. Exp. Ther. 1993; 266: 1649-1655.
55. Kaiser E, Colescott RL, Bossinger CD, Cook PI. Color test for detection of free terminal amino groups in solid-phase synthesis of peptides. Anal. Biochem. 1970; 34: 595-598.
56. Ellman GM. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959; 82: 70-77.
57. Kuisle O, Lolo M, Quiñoa E, Riguera R. Monitoring the solid-phase synthesis of depsides and depsipeptides. A color test for hydroxyl groups linked to a resin. Tetrahedron 1999; 55: 14 807-14 812.
58. Madder A, Farcy N, Hosten NGC, De Muynck H, De Clercq PJ, Barry J, Davis AP. A novel sensitive colorimetric assay for visual detection of solid-phase-bound amines. Eur. J. Org. Chem. 1999; 11: 2787-2791.
59. Goldberg DE. Genetic Algorithms in Search, Optimization and Machine Learning. Addison-Wesley Pub. Co., Boston, 1989.